Delivery Order SPE2DR25D1205-SPE2DR26F0XM2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of LEQVIO 284 mg/1.5 ml syringes with a contract ceiling value of $7,352.31. This firm fixed-price delivery order, which is not set-aside and carries an ultimate completion date of December 5, 2025, represents a competitively awarded procurement. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 18, 2025, by the Defense Logistics Agency (DLA) for the supply of LEQVIO 284 mg/1.5 mL syringes with a ceiling value of $16,278.85. This firm fixed-price delivery order, which is scheduled for completion by July 11, 2025, is unset-aside and competitively awarded. The award represents a continuation of the company's substantial role as a critical...
- AmerisourceBergen Drug Corp was awarded a $7,352.31 delivery order by the Defense Logistics Agency (DLA) on October 31, 2025, for the supply of LEQVIO 284 mg/1.5 mL syringes. This firm fixed-price, non-set-aside contract is scheduled for completion by November 24, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $24,507.70 to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 mL syringes. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of December 30, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The award involved no set-aside designation, allowing the contract to be competed among qualified vendors capable of meeting federal...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of LEQVIO 284 MG/1.5 ML syringes. This $4,394.82 delivery order is part of a larger $999,999,999.00 indefinite delivery contract awarded solely to Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to support the Department of Defense. The contract has an...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $2,197.41 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract is a firm fixed price award with a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,197.41 firm fixed price delivery order contract to provide LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,255.50 to AmerisourceBergen Drug Corp for the supply of Leqvio 284 mg/1.5 mL syringes. This firm fixed-price delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of June 12, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $2,197.41, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 16, 2024. AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
- The Defense Logistics Agency awarded a delivery order contract valued at $5,452.47 to AmerisourceBergen Drug Corp on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation. The...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0XM2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of LEQVIO 284 mg/1.5 mL syringes with a contract ceiling value of $4,901.54 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical division, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and supplies a comprehensive range of pharmaceutical products and medical commodities to support military healthcare systems worldwide. The company's contract awards with the Defense Logistics Agency demonstrate extensive experience in delivering brand-name and generic medications, vaccines, medical devices, and specialty healthcare supplies across multiple therapeutic domains. The SPE2DX indefinite delivery vehicle enables AmerisourceBergen to fulfill pharmaceutical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with flexible delivery mechanisms and competitive pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 12/2/25 |